Iambic Therapeutics

Iambic Therapeutics is a cutting-edge AI-driven drug discovery platform that tackles the most challenging design problems in drug discovery, addressing unmet patient need. Its physics-based AI algorithms drive a high-throughput experimental platform, converting new molecular designs to new biological insights each week. Iambic's platform optimizes target product profiles, exploring multiple profiles in parallel to ensure that molecules are designed to solve the right problems in disease biology. It also optimizes drug candidates, deeply exploring chemical space to reveal novel mechanisms of action and deliver diverse high-quality leads.

Atomwise is an AI-powered drug discovery company that uses machine learning to identify new small molecule medicines. The company's platform combines the power of convolutional neural networks with massive chemical libraries to discover new drug candidates. Atomwise has a portfolio of wholly owned and co-developed pipeline assets, and is backed by prominent investors.

Genesis Therapeutics is a cutting-edge platform that leverages molecular AI technology to discover and develop highly potent and selective medicines. Their proprietary AI platform, GEMS, combines AI and physics research to target challenging protein structures and create innovative drug candidates with exceptional efficacy. The company's success is driven by a collaborative approach, bringing together experts in AI and biotech to tackle complex drug discovery challenges.

OpenAI Strawberry Model is a cutting-edge AI initiative that represents a significant leap in AI capabilities, focusing on enhancing reasoning, problem-solving, and complex task execution. It aims to improve AI's ability to handle mathematical problems, programming tasks, and deep research, including long-term planning and action. The project showcases advancements in AI safety and aims to reduce errors in AI responses by generating high-quality synthetic data for training future models. Strawberry is designed to achieve human-like reasoning and is expected to play a crucial role in the development of OpenAI's next major model, codenamed 'Orion.'

VantAI is an AI application focused on generative AI-enabled drug discovery. Their mission is to unlock a new chapter in medicine by making protein interactions programmable. They have an integrated discovery platform with phase-shifting technologies designed to unlock the full potential of the proximity modulator modality. VantAI collaborates with industry leaders to build the future of therapeutic design. The company has launched Neo-1, the first AI model to rewire molecular interactions by unifying structure prediction and generation.

Nucleai is an AI-driven spatial biomarker analysis tool that leverages military intelligence-grade geospatial AI methods to analyze complex cellular interactions in a patient's biopsy. The platform offers a first-of-its-kind multimodal solution by ingesting images from various modalities and delivering actionable insights to optimize biomarker scoring, predict response to therapy, and revolutionize disease diagnosis and treatment.

Exscientia is a technology-driven drug design and development company that combines precision design with integrated experimentation to create more effective medicines for patients faster. They operate at the interfaces of human ingenuity, artificial intelligence (AI), automation, and physical engineering, pioneering the use of AI in drug discovery. Exscientia aims to change the underlying economics of drug discovery by rapidly advancing the best scientific ideas into medicines for patients.

Shaped is an AI tool designed to provide relevant recommendations and search results to increase engagement, conversion, and revenue. It offers a configurable system that adapts in real-time, with features such as easy set-up, real-time adaptability, state-of-the-art model library, high customizability, and explainable results. Shaped is suitable for technical teams and offers white-glove support. It specializes in real-time ranking systems and supports multi-modal unstructured data understanding. The tool ensures secure infrastructure and has advantages like increased redemption rate, average order value, and diversity.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus's innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, a tool to identify and close gaps in care; LENS, a platform to find, access, and analyze multimodal real-world data; and ALGOS, algorithmic models connected to Tempus's assays to provide additional insight.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

Modality.AI is an AI application that has developed an automated, clinically validated system to assess neurological and psychiatric states both in clinic and remotely. The platform utilizes conversational AI to monitor conditions accurately and consistently, allowing researchers and clinicians to review data in near real-time and monitor treatment response over time. Modality.AI collaborates with world-class AI/Machine Learning experts and leading institutions to provide a HIPAA-compliant system for assessing various indications such as ALS, Parkinson's, depression, autism, Huntington's Disease, schizophrenia, and mild cognitive impairment. The platform enables convenient monitoring at home through streaming and analysis of speech and facial responses, without the need for special software or apps. Modality.AI is accessible on various devices with a browser, webcam, and microphone, offering a new approach to efficient and cost-effective clinical trials.

Nuanced is an AI tool that detects AI-generated images to protect the integrity and authenticity of online services. It helps platforms combat fraud, deepfakes, and inauthentic content by distinguishing between genuine human-authored artifacts and AI-generated content. Nuanced's algorithms stay ahead of the accelerating changes in AI content generation, providing a privacy-first solution that is simple to adopt and integrate. With Nuanced, businesses can focus on their core operations while ensuring the authenticity of their content.

FlyPix is an AI-enabled geospatial solutions platform that leverages advanced AI technology to transform object detection, localization, tracking, and monitoring in the field of geospatial technology. The platform offers a wide range of capabilities, including AI-driven object analysis, change and anomaly detection, dynamic tracking, and custom use cases tailored to meet unique industry needs. FlyPix aims to provide unparalleled precision and efficiency in operations by converting complex imagery into actionable, geo-referenced insights.

SmartEq.ai is an AI-driven platform that revolutionizes the development of groundbreaking technology products through innovative approaches. The platform leverages cutting-edge AI tools like Nostradamus for market research and equity distribution, empowering end users to shape and own the products. SmartEq.ai also offers a unique equity crowdfunding platform, saaseq.app, to democratize access to early-stage investment opportunities. By fostering a collaborative and rewarding ecosystem, SmartEq.ai is redefining the traditional boundaries between SaaS startups and users, driving innovation in the tech industry.

Lavo Life Sciences is an AI-accelerated crystal structure prediction application that helps in drug development by providing accurate predictions for small molecule drugs. The application utilizes AI technology to optimize solid-state formulations, reduce turnaround time, mitigate risks, and discover novel polymorphs, ultimately streamlining the pharmaceutical research and development process.

Weavel is an AI tool designed to revolutionize prompt engineering for large language models (LLMs). It offers features such as tracing, dataset curation, batch testing, and evaluations to enhance the performance of LLM applications. Weavel enables users to continuously optimize prompts using real-world data, prevent performance regression with CI/CD integration, and engage in human-in-the-loop interactions for scoring and feedback. Ape, the AI prompt engineer, outperforms competitors on benchmark tests and ensures seamless integration and continuous improvement specific to each user's use case. With Weavel, users can effortlessly evaluate LLM applications without the need for pre-existing datasets, streamlining the assessment process and enhancing overall performance.

Recursion is a techbio company that uses artificial intelligence to accelerate drug discovery. The company's platform combines hardware, software, and data to create a more efficient and effective drug discovery process. Recursion has a broad pipeline of drug candidates in development, and it has partnered with several leading pharmaceutical companies. The company is headquartered in Salt Lake City, Utah.

Iambic Therapeutics is a cutting-edge AI-driven drug discovery platform that tackles the most challenging design problems in drug discovery, addressing unmet patient need. Its physics-based AI algorithms drive a high-throughput experimental platform, converting new molecular designs to new biological insights each week. Iambic's platform optimizes target product profiles, exploring multiple profiles in parallel to ensure that molecules are designed to solve the right problems in disease biology. It also optimizes drug candidates, deeply exploring chemical space to reveal novel mechanisms of action and deliver diverse high-quality leads.

Atomwise is an AI-powered drug discovery company that uses machine learning to identify new small molecule medicines. The company's platform combines the power of convolutional neural networks with massive chemical libraries to discover new drug candidates. Atomwise has a portfolio of wholly owned and co-developed pipeline assets, and is backed by prominent investors.

JADBio is an automated machine learning (AutoML) platform designed to accelerate biomarker discovery and drug development processes. It offers a no-code solution that automates the discovery of biomarkers and interprets their role based on research needs. JADBio can parse multi-omics data, including genomics, transcriptome, metagenome, proteome, metabolome, phenotype/clinical data, and images, enabling users to efficiently discover insights for various conditions such as cancer, immune system disorders, chronic diseases, infectious diseases, and mental health. The platform is trusted by partners in precision health and medicine and is continuously evolving to disrupt drug discovery times and costs at all stages.

Cradle is a protein engineering platform that uses machine learning to design improved protein sequences. It allows users to import assay data, generate new sequences, test them in the lab, and import the results to improve the model. Cradle can be used to optimize multiple properties of a protein simultaneously, and it has been used by leading biotech teams to accelerate new and ongoing projects.

PubCompare is a powerful AI-powered tool that helps scientists search, compare, and evaluate experimental protocols. With over 40 million protocols in its database, PubCompare is the largest repository of trusted experimental protocols. PubCompare's AI-powered search features allow users to find similar protocols, highlight critical steps, and evaluate the reproducibility of protocols based on in-protocol citations. PubCompare is available from any computer and requires no download.

Insitro is a drug discovery and development company that uses machine learning and data to identify and develop new medicines. The company's platform integrates in vitro cellular data produced in its labs with human clinical data to help redefine disease. Insitro's pipeline includes wholly-owned and partnered therapeutic programs in metabolism, oncology, and neuroscience.

Deep Genomics is a company that uses artificial intelligence (AI) to develop RNA therapies for genetic diseases. The company's AI platform is designed to identify novel targets and evaluate thousands of possibilities to identify the best therapeutic candidates. Deep Genomics is currently developing BigRNA+, which will expand the number of mechanisms and genetic variants the company can pursue.

BenevolentAI is a leader in applying advanced AI to accelerate biopharma drug discovery blending science and technology with a focus on finding solutions for complex diseases. We empower both biopharmaceutical companies and our internal scientists to harness the full potential of data and AI to accelerate the next generation of scientific advances. We have built our AI-enabled drug discovery engine to drive a revolution in drug discovery. The Benevolent Platform™ unlocks the power of a vast biomedical data landscape to provide a multidimensional representation of human biology across all diseases. We believe this approach will improve the probability of clinical success, and help us deliver life-changing treatments to patients – because it matters.

XtalPi is a world-leading technology company driven by artificial intelligence (AI) and robotics to innovate in the fields of life sciences and new materials. Founded in 2015 at the Massachusetts Institute of Technology (MIT), the company is committed to realizing digital and intelligent innovation in the fields of life sciences and new materials. Based on cutting-edge technologies and capabilities such as quantum physics, artificial intelligence, cloud computing, and large-scale experimental robot clusters, the company provides innovative technologies, services, and products for global industries such as biomedicine, chemicals, new energy, and new materials.

Iambic Therapeutics is a cutting-edge AI-driven drug discovery platform that tackles the most challenging design problems in drug discovery, addressing unmet patient need. Its physics-based AI algorithms drive a high-throughput experimental platform, converting new molecular designs to new biological insights each week. Iambic's platform optimizes target product profiles, exploring multiple profiles in parallel to ensure that molecules are designed to solve the right problems in disease biology. It also optimizes drug candidates, deeply exploring chemical space to reveal novel mechanisms of action and deliver diverse high-quality leads.

Tempus is an AI-enabled precision medicine company that brings the power of data and artificial intelligence to healthcare. With the power of AI, Tempus accelerates the discovery of novel targets, predicts the effectiveness of treatments, identifies potentially life-saving clinical trials, and diagnoses multiple diseases earlier. Tempus' innovative technology includes ONE, an AI-enabled clinical assistant; NEXT, which identifies and closes gaps in care; LENS, which finds, accesses, and analyzes multimodal real-world data; and ALGOS, algorithmic models connected to Tempus' assays to provide additional insight.

Bionl is a no-code bioinformatics platform designed to streamline biomedical research for researchers and scientists. It offers a full workspace with features such as bioinformatics pipelines customization, GenAI for data analysis, AI-powered literature search, PDF analysis, and access to public datasets. Bionl aims to automate cloud, file system, data, and workflow management for efficient and precise analyses. The platform caters to Pharma and Biotech companies, academic researchers, and bioinformatics CROs, providing powerful tools for genetic analysis and speeding up research processes.

Genie TechBio is the world's first AI bioinformatician, offering an LLM-powered omics analysis software that operates entirely in natural language, eliminating the need for coding. Researchers can effortlessly analyze extensive datasets by engaging in a conversation with Genie, receiving recommendations for analysis pipelines, and obtaining results. The tool aims to accelerate biomedical research and empower scientists with newfound data analysis capabilities.

HoloEye.AI is a transformative AI biological intelligence company that leverages cutting-edge artificial intelligence technology to revolutionize the field of biological research. The platform offers advanced AI solutions for analyzing complex biological data, enabling researchers to gain deeper insights and accelerate scientific discoveries.

Mapmygenome is an AI-powered platform that offers DNA testing products for health, fitness, and beauty. It provides personalized insights based on genetic analysis to help individuals make informed decisions about their health, wellness, and lifestyle choices. With over 23 years of genomics experience and the latest sequencing technology, Mapmygenome aims to empower users to take proactive steps towards improving their overall well-being.

Chemprop is a PyTorch-based framework for training and evaluating message-passing neural networks (MPNNs) for molecular property prediction. Originally developed for research purposes, Chemprop offers a comprehensive set of tools and features for training models and analyzing molecular representations. The package underwent a recent major release (v2.0.0) with significant improvements and updates.

Variational AI is a company that uses generative AI to discover novel drug-like small molecules with optimized properties for defined targets. Their platform, Enki™, is the first commercially accessible foundation model for small molecules. It is designed to make generating novel molecule structures easy, with no data required. Users simply define their target product profile (TPP) and Enki does the rest. Enki is an ensemble of generative algorithms trained on decades worth of experimental data with proven results. The company was founded in September 2019 and is based in Vancouver, BC, Canada.

Cambrian Copilot is an AI tool designed for researchers and engineers to stay up-to-date with the latest machine learning research. The tool enables users to search over 240,000 ML papers, understand complex details, and automate literature reviews. It simplifies the process of discovering and accessing the most recent research developments in the field of machine learning.

Mnemonic AI is an advanced Customer Intelligence AI tool that specializes in creating AI Personas and Digital Twins of customers. The tool helps organizations of all sizes better understand individuals by developing artificial intelligence solutions to tailor messages based on customer beliefs, personality, and values. Mnemonic AI offers features such as Buyer Persona Creation, Digital Twin of The Customer, Case Studies, Whitepaper, OCEAN Personality Analysis, Schwartz Universal Values, and easy integrations with data sources.

functime is a time-series machine learning tool designed to perform forecasting tasks at scale. It provides a comprehensive set of functions and features to help users analyze and compare trends, seasonality, and causal factors in their forecasts. With easy installation via pip, detailed documentation, and a user-friendly tutorial, functime is suitable for both beginners and experienced users in the field of machine learning. The tool offers evaluation procedures for scoring, ranking, and plotting thousands of forecasts simultaneously, making it a valuable asset for data analysts and forecast analysts.

Kolank is an AI tool that offers a unified API for various AI models with features like load balancing, fallbacks, cost and performance metrics. It provides access to a range of models for tasks such as text generation, image analysis, and video processing. Users can interact with the API using popular programming languages like Python and JavaScript, as well as through command-line tools like Curl. Kolank aims to simplify the integration of AI capabilities into applications and workflows, making it easier for developers to leverage advanced AI technologies.

StockGPT is an AI-powered financial research assistant that provides users with knowledge of earnings releases, financial reports, and other fundamental information for S&P 500 and Nasdaq companies. It offers features like AI search, customizable filters, industry research, and up-to-date data to help users analyze companies and markets more efficiently.

XenonStack is an AI tool that offers a comprehensive suite of solutions for building agentic systems, leveraging cutting-edge technologies like AI, data analytics, and automation. The platform caters to various industries and business sectors, providing services such as AI transformation, decision modeling, AI assurance, and cloud architecture. XenonStack aims to enhance business workflows, optimize decision-making processes, and drive operational efficiency through the deployment of intelligent AI agents and automation.

Google Colab Copilot is an AI tool that integrates the GitHub Copilot functionality into Google Colab, allowing users to easily generate code suggestions and improve their coding workflow. By following a simple setup guide, users can start using the tool to enhance their coding experience and boost productivity. With features like code generation, auto-completion, and real-time suggestions, Google Colab Copilot is a valuable tool for developers looking to streamline their coding process.

Data Zenith is a Kolkata-based startup specializing in innovative data analytics solutions. They offer tailored analytics services to help businesses unlock the potential of their data, streamline operations, and make informed decisions for sustainable growth. With a team of experienced data scientists, Data Zenith provides comprehensive data analysis, predictive analytics, and data visualization services to drive actionable insights and enhance operational efficiency.

Lobe is a machine learning tool that helps users train machine learning models and ship them to any platform of their choice. It provides a user-friendly interface for creating and managing machine learning projects, making it easy for both beginners and experienced users to work with AI models.